首页> 美国卫生研究院文献>PLoS Clinical Trials >Large-Scale Sequence Analysis of Hemagglutinin of Influenza A Virus Identifies Conserved Regions Suitable for Targeting an Anti-Viral Response
【2h】

Large-Scale Sequence Analysis of Hemagglutinin of Influenza A Virus Identifies Conserved Regions Suitable for Targeting an Anti-Viral Response

机译:甲型流感病毒血凝素的大规模序列分析确定了适合靶向抗病毒应答的保守区

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundInfluenza A viral surface protein, hemagglutinin, is the major target of neutralizing antibody response and hence a main constituent of all vaccine formulations. But due to its marked evolutionary variability, vaccines have to be reformulated so as to include the hemagglutinin protein from the emerging new viral strain. With the constant fear of a pandemic, there is critical need for the development of anti-viral strategies that can provide wider protection against any Influenza A pathogen. An anti-viral approach that is directed against the conserved regions of the hemaggutinin protein has a potential to protect against any current and new Influenza A virus and provide a solution to this ever-present threat to public health.
机译:背景甲型病毒表面蛋白血凝素是中和抗体反应的主要目标,因此是所有疫苗制剂的主要成分。但是由于其显着的进化变异性,必须重新配制疫苗,以包括来自新出现的新病毒株的血凝素蛋白。由于人们一直担心大流行,因此迫切需要开发抗病毒策略,以提供针对任何甲型流感病原体的更广泛保护。针对血凝素蛋白保守区域的抗病毒方法有潜力预防任何当前和新的甲型流感病毒,并为这种对公共健康的不断威胁提供解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号